RT Book, Section
A1 Sahni, Gagan
A1 Scarabelli, Tiziano
A1 Yeh, Edward T.H.
A2 Fuster, Valentin
A2 Harrington, Robert A.
A2 Narula, Jagat
A2 Eapen, Zubin J.
SR Print(0)
ID 1192038766
T1 THE DIAGNOSIS AND MANAGEMENT OF CARDIOVASCULAR DISEASE IN PATIENTS WITH CANCER
T2 Hurst's The Heart, 14e
YR 2017
FD 2017
PB McGraw-Hill Education
PP New York, NY
SN 9780071843249
LK accesscardiology.mhmedical.com/content.aspx?aid=1192038766
RD 2024/04/23
AB With  the  advent  of  more  effective  cancer  treatments  and  the  increasing  likelihood  of  an  earlier  cancer  diagnosis,  patients  with  many  forms  of  cancer  can  expect  to  either  be  cured  of  their  disease  or  have  their  disease  stabilized  by  maintenance  therapy.  Although  the  overall  rate  of  cancer  incidence  has  declined  since  the  early  2000s,1  cancers  necessitating  aggressive  chemotherapy,  including  melanoma,  non-Hodgkin  lymphoma,  leukemia,  and  those  of  the  pancreas  and  esophagus  have  been  on  the  rise.  Accompanying  this  trend,  the  length  of  cancer  survival  has  increased  for  all  cancers  combined.  The  5-year  survival  rate  for  all  cancers  combined  improved  from  66.7%  in  2003  to  68%  in  2009.1  This  implies  that  cancer  survivors  now  live  longer,  allowing  the  manifestation  of  potential  cardiac  side  effects  of  chemotherapeutic  agents  as  well  as  the  age-related  increase  in  the  risk  of  cardiovascular  disease.